RE: broker note1 Apr 2022 14:04
Investment summary: During 2021, Cizzle delivered a regular flow of development and partnership news, and this is continuing into 2022. Much depends on the delivery of antibodies by FairJourney, which will allow the company to move forward with its own and collaborative projects. An EV of just £5.8m suggests that there is considerable upside potential when investors become more aware of Cizzle, and as further deals are announced.